Salemonline Journal

Artificial Intelligence in Drug Discovery Market Size [2022-2027] | Industry Share, Revenue, Key Players, CAGR, Demand and Forecast by DelveInsight

 Breaking News
  • No posts were found

Artificial Intelligence in Drug Discovery Market Size [2022-2027] | Industry Share, Revenue, Key Players, CAGR, Demand and Forecast by DelveInsight

May 11
18:52 2023
Artificial Intelligence in Drug Discovery Market Size [2022-2027] | Industry Share, Revenue, Key Players, CAGR, Demand and Forecast by DelveInsight
Artificial Intelligence in Drug Discovery Market

DelveInsight’s Artificial Intelligence in Drug Discovery Market Insights report provides the current and forecast market analysis, individual leading Artificial Intelligence in Drug Discovery companies’ market shares, challenges, Artificial Intelligence in Drug Discovery market drivers, barriers, and trends, and key Artificial Intelligence in Drug Discovery companies in the market.

 

Request for Sample Page @ Artificial Intelligence in Drug Discovery Market Forecast

 

Key Takeaways from the Artificial Intelligence in Drug Discovery Market Report

  • The Global Artificial Intelligence in Drug Discovery Market to Grow Immensely at a CAGR of ~37% by 2027.
  • As per DelveInsight estimates, North America is anticipated to dominate the global Artificial Intelligence in Drug Discovery market during the forecast period.
  • Notable Artificial Intelligence in Drug Discovery companies such as IBM Corporation, NuMedii Inc, Deep Genomics, NVIDIA Corporation, Atomwise Inc, Cloud Pharmaceuticals, Alphabet Inc (Deep Mind), Insilico Medicine, BenevolentAI, Exscientia, Cyclica, Valo Health Owkin, Verge Genomics, BioSymetics, BeiGene, and several others are currently operating in the Artificial Intelligence in Drug Discovery market.
  • In January 2022, Sanofi entered into a research collaboration with Exscientia, which uses artificial intelligence to discover new drug candidates that could be worth up to USD 5.2 billion for the latter company.
  • In December 2021, Insilico Medicine announced the start of the world’s first Phase I clinical trial of a drug developed from scratch using AI. Its end-to-end platform applies AI to biology for target discovery, and to chemistry for drug design. The AI-designed drug is a small-molecule inhibitor and is developed for the treatment of idiopathic pulmonary fibrosis.

 

To read more about the latest highlights related to Artificial Intelligence in the Drug Discovery market, get a snapshot of the key highlights entailed in the Global Artificial Intelligence in Drug Discovery Market Report @ https://www.delveinsight.com/sample-request/artificial-intelligence-ai-in-drug-discovery-market

 

Artificial Intelligence in Drug Discovery Overview:

Artificial intelligence (AI) in drug discovery is the utilisation of advanced computing techniques such machine learning, artificial neural networks, and natural language processing to process large amounts of data to help with target, lead identification and other required inputs for drug discovery and development.

Among all the regions, North America is estimated to amass the largest revenue share in the global AI in drug discovery market in the year 2021. This can be ascribed to the presence of large patient population associated with various diseases including cancers, neurological disorders which in turn drive the demand for various drugs with minimal side effects. Moreover, the extensive focus on clinical research and the presence of key players in the region from both the pharmaceutical as well as the technology domains further help in the growth of the North America AI in drug discovery market.

 

Request for free AI in Drug Discovery Market Sample page @ https://www.delveinsight.com/sample-request/artificial-intelligence-ai-in-drug-discovery-market

 

Artificial Intelligence in Drug Discovery Market Dynamics

The AI in drug discovery market is witnessing a positive market growth owing to the factors such as rising prevalence of various diseases across the globe which have necessitated the need for faster development of highly safe and efficacious drugs. Moreover, the realization of the advantages of AI in pharmaceutical sector is further motivating pharma companies and institutes to further invest in drug research and development. Additionally, the extensive partnerships and collaborations between public and private entities and both national and international levels are further expected to boost the AI in drug discovery market.

 

Scope of the Artificial Intelligence in Drug Discovery Market Report:

  • Coverage: Global
  • Study Period: 2019–2027
  • Base Year: 2021
  • Artificial Intelligence in Drug Discovery Market CAGR: ~37%
  • Key Artificial Intelligence in Drug Discovery Companies: IBM Corporation, NuMedii Inc, Deep Genomics, NVIDIA Corporation, Atomwise Inc, Cloud Pharmaceuticals, Alphabet Inc (Deep Mind), Insilico Medicine, BenevolentAI, Exscientia, Cyclica, Valo Health Owkin, Verge Genomics, BioSymetics, BeiGene, among others
  • Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
  • Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View

 

Which MedTech key players in the Artificial Intelligence in Drug Discovery market are set to emerge as the trendsetter explore @ https://www.delveinsight.com/sample-request/artificial-intelligence-ai-in-drug-discovery-market

 

Table of Contents

1. Artificial Intelligence in Drug Discovery Report Introduction

2. Executive summary

3. Artificial Intelligence in Drug Discovery Regulatory and Patent Analysis

4. Key Factors Analysis

5. Porter’s Five Forces Analysis

6. COVID-19 Impact Analysis on Artificial Intelligence in Drug Discovery Market

7. Artificial Intelligence in Drug Discovery Market Layout

8. Global Company Share Analysis – Key 3-5 Companies

9. Artificial Intelligence in Drug Discovery Market Company and Product Profiles

10. Project Approach

11. About DelveInsight

 

Interested in knowing the Artificial Intelligence in Drug Discovery market by 2027? Click to get a snapshot of the Artificial Intelligence in Drug Discovery Market Trends @ https://www.delveinsight.com/sample-request/artificial-intelligence-ai-in-drug-discovery-market

 

About DelveInsight

DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting